Company intelligence / Profile preview

Highline Therapeutics

New York City, New York, United States

Ownership: Private
Development stage: Other

Overview

Highline Therapeutics was a Versant Ventures-backed biotech incubator in New York City, focused on accelerating translational research in oncology and immunology. Its related entity, Highline Sciences LLC, a CRO specializing in oncology clinical trials, was acquired by Tempus AI in 2022.

Industry: Investors

Partnerships

Weill Cornell Medical CollegeVersant Ventures

Beyond the preview

Go deeper on Highline Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Highline Therapeutics.

Explore the full profile